SCHEMBL20921978

SCHEMBL20921978

CC(C)CC(=O)CC(=O)OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
ALDH1A1 P00352 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CA12 O43570 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CTSK P43235 1/20 0.35
DGAT1 O75907 1/20 0.34
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP9 P14780 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1260232 0.86 CYP2D6 (0.47) CYP2D6CA1CA2CA7HDAC3
SCHEMBL6503240 0.86 CYP2D6 (0.47) CYP2D6CA1CA2CA7HDAC3
SCHEMBL1260230 0.86 CYP2D6 (0.47) CYP2D6CA1CA2CA7HDAC3
SCHEMBL28836831 0.84 CYP2D6 (0.42) CYP2D6CA1CA2CA7HDAC3
SCHEMBL31698005 0.84 CYP2D6 (0.42) CYP2D6CA1CA2CA7HDAC3
SCHEMBL2690899 0.82 CYP2D6 (0.55) CYP2D6CYP2C19CA1CA2CA7
SCHEMBL2648388 0.82 DGAT1 (0.42) CYP2D6CA1CA2CA7HDAC3
SCHEMBL27277877 0.82 CYP2D6 (0.44) CYP2D6CA1CA2CA7HDAC3
SCHEMBL31466178 0.80 CYP2D6 (0.39) CYP2D6CA1CA2CA7HDAC3
SCHEMBL24345707 0.80 CYP2D6 (0.54) CYP2D6CYP2C19CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106661395-B Workpiece fixing sheet with resin layer 琳得科株式会社 2021-05-28 CN disclosed
EP-3149001-B1 NOVEL PYRAZOLO PYRIMIDINE DERIVATIVES AND THEIR USE AS MALT1 INHIBITORS NOVARTIS AG (CH) 2019-04-24 EP disclosed